Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
AdaptHealth Corp. (AHCO) · oqro.io/stocks/AHCO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Since the trade +19.1% · S&P 500 −10.3% · to Nov 20
Bought at the 52-week low, RSI 19, 42% under its 200-day average, 52 points behind the S&P 500 over 3 months
An AdaptHealth director paid $126K out of pocket for AdaptHealth shares. 1 other person at AdaptHealth bought some too, in the same month. It was the first purchase in 6 months.
First buy since 2021Traded Feb 27 · filed 4 days later
Since the trade −21.3% · S&P 500 +0.6% · to Nov 20
Bought 20% below the 52-week high, RSI 38, 3% under its 200-day average
An AdaptHealth director paid $72K out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month. Shares held went up 8% with this purchase.
An AdaptHealth director paid $150K out of pocket for AdaptHealth shares. 1 other person at AdaptHealth bought some too, in the same month. Shares held went up 94% with this purchase.
AdaptHealth's CLO and General Counsel paid $45K out of pocket for AdaptHealth shares. 3 other people at AdaptHealth bought some too, in the same month.
14 open-market purchases and 2 open-market sales by insiders of AHCO between Jan 25, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 3, 2026. The data provider lists the next release for Feb 22, 2027; that date may change.
PurchaseSale30 days before a release30 days after
Trades in the 30 days around each of the last earnings releases
Dale B Wolf, Director, Aug 6, 2026, about $126K. Bought 2 days after the company's previous earnings release on 2026-08-04Form 4
Kenneth A Samet, Director, Aug 6, 2026, about $150K. Bought 2 days after the company's previous earnings release on 2026-08-04Form 4
Iii Russell E. Schuster, Chief Commercial Officer, Jul 1, 2026, about $118K. Sold 34 days before the company's next earnings release on 2026-08-04Form 4
Iii Russell E. Schuster, Chief Commercial Officer, Jun 1, 2026, about $113K. Sold 27 days after the company's previous earnings release on 2026-05-05Form 4
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies
OEP VII GP, L.L.C., Mar 20, 2026, about $4.43M. Bought 24 days after the company's previous earnings release on 2026-02-24